ChemicalBook > CAS DataBase List > (S)-ROSCOVITINE

(S)-ROSCOVITINE

Product Name
(S)-ROSCOVITINE
CAS No.
186692-45-5
Chemical Name
(S)-ROSCOVITINE
Synonyms
Roscovitine, (S)-Isomer - CAS 186692-45-5 - Calbiochem;(2S)-2-[[9-(1-Methylethyl)-6-[(phenylmethyl)amino]-9H-purin-2-yl]amino]-1-butanol;1-Butanol, 2-[[9-(1-methylethyl)-6-[(phenylmethyl)amino]-9H-purin-2-yl]amino]-, (2S)-
CBNumber
CB71498962
Molecular Formula
C19H26N6O
Formula Weight
354.45
MOL File
186692-45-5.mol
More
Less

(S)-ROSCOVITINE Property

Melting point:
103-106℃
Density 
1.25
storage temp. 
-20C
form 
White solid
color 
White to off-white
More
Less

Hazard and Precautionary Statements (GHS)

More
Less

N-Bromosuccinimide Price

Adipogen Life Sciences
Product number
AG-MR-C0002-M005
Product name
(S)-Roscovitine
Purity
≥99%(NMR)
Packaging
5mg
Price
$90
Updated
2021/12/16
American Custom Chemicals Corporation
Product number
KIN0000007
Product name
(S)-ROSCOVITINE
Purity
95.00%
Packaging
1MG
Price
$456
Updated
2021/12/16
American Custom Chemicals Corporation
Product number
KIN0000007
Product name
(S)-ROSCOVITINE
Purity
95.00%
Packaging
5MG
Price
$802.38
Updated
2021/12/16
More
Less

(S)-ROSCOVITINE Chemical Properties,Usage,Production

Uses

(S)-Roscovitine ((S)-Seliciclib; (S)-CYC202) is a potent and cross the blood-brain barrier CDKs inhibitor. (S)-Roscovitine shows neuroprotective efficacy. (S)-Roscovitine has the potential for the research of stroke[1][2].

in vivo

(S)-Roscovitine (25 mg/kg; i.p.; 15 min before and 1 hr after pMCAo) shows neuroprotective efficacy in an adult mouse model of permanent MCAo (middle cerebral artery occlusion) [2].

Animal Model:20-25 g, P60 male C57 b/6 mice[2]
Dosage:25 mg/kg
Administration:I.p.; at 15 min before and 1 hr after pMCAo
Result:Decreased of the total infarct volume.

IC 50

CDK1: ≤1 μM (IC50); CDK2: ≤1 μM (IC50); CDK5: ≤1 μM (IC50); CDK7: ≤1 μM (IC50); CDK9: ≤1 μM (IC50)

storage

+4°C

References

[1] Le Roy L, et al. Cellular and Molecular Mechanisms of R/S-Roscovitine and CDKs Related Inhibition under Both Focal and Global Cerebral Ischemia: A Focus on Neurovascular Unit and Immune Cells. Cells. 2021 Jan 8;10(1):104. DOI:10.3390/cells10010104
[2] Menn B, et al. Delayed treatment with systemic (S)-roscovitine provides neuroprotection and inhibits in vivo CDK5 activity increase in animal stroke models. PLoS One. 2010 Aug 12;5(8):e12117. DOI:10.1371/journal.pone.0012117

(S)-ROSCOVITINE Preparation Products And Raw materials

Raw materials

Preparation Products

More
Less

(S)-ROSCOVITINE Suppliers

Shanghai EFE Biological Technology Co., Ltd.
Tel
021-65675885 18964387627
Fax
021-65675885
Email
info@efebio.com
Country
China
ProdList
9803
Advantage
58
Tianjin Kailiqi Biotechnology Co., Ltd.
Tel
15076683720
Fax
022-23754520
Email
klq@cw-bio.com
Country
China
ProdList
8011
Advantage
55
TargetMol Chemicals Inc.
Tel
15002134094
Email
marketing@targetmol.cn
Country
China
ProdList
29496
Advantage
58
Enzo Biochem Inc
Tel
Enzo Biochem Inc. 13797054060
Email
Enzoname@qq.com
Country
China
ProdList
6174
Advantage
58
Biosynth Biological Technology (Suzhou) Co Ltd
Tel
51288865780
Email
sales@biosynth.com
Country
China
ProdList
6051
Advantage
58
Qingdao Everest Technology & Trade Co., Ltd.
Tel
13792478491
Country
CHINA
ProdList
161
Advantage
58

186692-45-5, (S)-ROSCOVITINERelated Search:


  • (2S)-2-[[9-(1-Methylethyl)-6-[(phenylmethyl)amino]-9H-purin-2-yl]amino]-1-butanol
  • Roscovitine, (S)-Isomer - CAS 186692-45-5 - Calbiochem
  • 1-Butanol, 2-[[9-(1-methylethyl)-6-[(phenylmethyl)amino]-9H-purin-2-yl]amino]-, (2S)-
  • 186692-45-5
  • C19H26N6O